Jurjen van der Schans

811 total citations
45 papers, 480 citations indexed

About

Jurjen van der Schans is a scholar working on Epidemiology, Economics and Econometrics and Psychiatry and Mental health. According to data from OpenAlex, Jurjen van der Schans has authored 45 papers receiving a total of 480 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 10 papers in Economics and Econometrics and 9 papers in Psychiatry and Mental health. Recurrent topics in Jurjen van der Schans's work include Health Systems, Economic Evaluations, Quality of Life (8 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Vaccine Coverage and Hesitancy (6 papers). Jurjen van der Schans is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (8 papers), Attention Deficit Hyperactivity Disorder (7 papers) and Vaccine Coverage and Hesitancy (6 papers). Jurjen van der Schans collaborates with scholars based in Netherlands, Indonesia and Uganda. Jurjen van der Schans's co-authors include Eelko Hak, Pieter J. Hoekstra, Tjalling W. de Vries, Maarten J. Postma, Joost J.C. Verhoeff, Herman W. Barkema, Jens Bos, Catharina C. M. Schuiling‐Veninga, Bob Wilffert and Cornelis Boersma and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Neuroscience & Biobehavioral Reviews.

In The Last Decade

Jurjen van der Schans

40 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jurjen van der Schans Netherlands 12 131 66 63 60 47 45 480
Tista S. Ghosh United States 12 49 0.4× 84 1.3× 140 2.2× 68 1.1× 24 0.5× 24 533
Naomi Launders United Kingdom 13 63 0.5× 269 4.1× 55 0.9× 143 2.4× 28 0.6× 31 560
Jack K. Leiss United States 13 115 0.9× 138 2.1× 80 1.3× 15 0.3× 44 0.9× 24 608
Kieran Moore Canada 14 61 0.5× 65 1.0× 192 3.0× 8 0.1× 41 0.9× 56 649
Xing-Yu Zhang China 7 50 0.4× 38 0.6× 58 0.9× 6 0.1× 37 0.8× 10 293
Clare F Aldus United Kingdom 11 63 0.5× 63 1.0× 38 0.6× 92 1.5× 18 0.4× 25 522
N Calvert United Kingdom 8 65 0.5× 32 0.5× 54 0.9× 30 0.5× 16 0.3× 10 391
Farzad Ebrahimzadeh Iran 14 53 0.4× 35 0.5× 172 2.7× 27 0.5× 48 1.0× 89 776
Rosemary Johann‐Liang United States 16 123 0.9× 259 3.9× 113 1.8× 26 0.4× 23 0.5× 28 842
Peter Hunter Australia 11 50 0.4× 23 0.3× 117 1.9× 16 0.3× 18 0.4× 32 523

Countries citing papers authored by Jurjen van der Schans

Since Specialization
Citations

This map shows the geographic impact of Jurjen van der Schans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jurjen van der Schans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jurjen van der Schans more than expected).

Fields of papers citing papers by Jurjen van der Schans

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jurjen van der Schans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jurjen van der Schans. The network helps show where Jurjen van der Schans may publish in the future.

Co-authorship network of co-authors of Jurjen van der Schans

This figure shows the co-authorship network connecting the top 25 collaborators of Jurjen van der Schans. A scholar is included among the top collaborators of Jurjen van der Schans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jurjen van der Schans. Jurjen van der Schans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Schans, Jurjen van der, Jaap Koot, Marcel J. W. Greuter, et al.. (2024). Early evaluation of a screen-and-treat strategy using high-risk HPV testing for Uganda: Implications for screening coverage and treatment. Journal of Global Health. 14. 4157–4157.
4.
Koot, Jaap, Geertruida H. de Bock, Marcel J. W. Greuter, et al.. (2024). High-risk human papillomavirus testing for cervical cancer screening in Uganda: Considering potential harms and benefits in a low-resource setting. PLoS ONE. 19(10). e0312295–e0312295.
5.
Alkaff, Firas Farisi, et al.. (2023). Economic Evaluations of Screening Programs for Chronic Kidney Disease: A Systematic Review. Value in Health. 27(1). 117–128. 8 indexed citations
6.
Arifin, Bustanul, Dyah Aryani Perwitasari, Retna Siwi Padmawati, et al.. (2023). The knowledge mapping of HIV/AIDS in Indonesians living on six major islands using the Indonesian version of the HIV-KQ-18 instrument. PLoS ONE. 18(11). e0293876–e0293876. 2 indexed citations
7.
8.
Schans, Jurjen van der, Jaap Koot, Janine de Zeeuw, et al.. (2023). EE685 Screen-and-Treat Cervical Cancer Screening Strategy Using High-Risk HPV Testing: Early Evaluation for Uganda. Value in Health. 26(12). S186–S186. 2 indexed citations
9.
Schans, Jurjen van der, Samuel Bawa, Balcha Masresha, et al.. (2023). The cost of implementing measles campaign in Nigeria: comparing the stand-alone and the integrated strategy. Health Economics Review. 13(1). 36–36. 5 indexed citations
10.
Arifin, Bustanul, Satibi Satibi, Dyah Aryani Perwitasari, et al.. (2022). Translation and performance of the Finnish Diabetes Risk Score for detecting undiagnosed diabetes and dysglycaemia in the Indonesian population. PLoS ONE. 17(7). e0269853–e0269853. 13 indexed citations
11.
Arifin, Bustanul, Dyah Aryani Perwitasari, Marianti A. Manggau, et al.. (2022). Adaptation and validation of the HIV Knowledge Questionnaire-18 for the general population of Indonesia. Health and Quality of Life Outcomes. 20(1). 55–55. 8 indexed citations
12.
13.
Schans, Jurjen van der, et al.. (2020). PRS27 Incorporating Heterogeneity in Risk for Infection and Disease in Cost-Effectiveness of Preventative Strategies in Older Adults. Value in Health. 23. S721–S721. 1 indexed citations
14.
Schans, Jurjen van der, Eelko Hak, Maarten J. Postma, et al.. (2019). Effects of Pharmacogenetic Screening for CYP2D6 Among Elderly Starting Therapy With Nortriptyline or Venlafaxine. Journal of Clinical Psychopharmacology. 39(6). 583–590. 15 indexed citations
15.
Postma, Maarten J., et al.. (2019). PNS123 IMPLEMENTATION OF UNIVERSAL HEALTH COVERAGE IN INDONESIA. Value in Health. 22. S782–S782. 1 indexed citations
16.
Schans, Jurjen van der, Aafje Dotinga, Bob Wilffert, et al.. (2018). Concordance assessment of self-reported medication use in the Netherlands three-generation Lifelines Cohort Study with the pharmacy database IADB.nl: The PharmLines Initiative. Clinical Epidemiology. Volume 10. 981–989. 43 indexed citations
17.
Koog, Luke van der, et al.. (2017). [Upward trend in the use of psychostimulants by adults].. PubMed. 161. D1660–D1660. 1 indexed citations
18.
Schans, Jurjen van der, et al.. (2017). Methylphenidate use and school performance among primary school children: a descriptive study. BMC Psychiatry. 17(1). 116–116. 5 indexed citations
19.
Schans, Jurjen van der, et al.. (2017). Association of atopic diseases and attention-deficit/hyperactivity disorder: A systematic review and meta-analyses. Neuroscience & Biobehavioral Reviews. 74(Pt A). 139–148. 121 indexed citations
20.
Barkema, Herman W., et al.. (2002). Herd-level diagnosis for Salmonella enterica subsp. enterica serovar Dublin infection in bovine dairy herds. Preventive Veterinary Medicine. 53(1-2). 31–42. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tista S. Ghosh Breakdown of academic impact, for papers by Naomi Launders Breakdown of academic impact, for papers by Jack K. Leiss Breakdown of academic impact, for papers by Kieran Moore Breakdown of academic impact, for papers by Xing-Yu Zhang Breakdown of academic impact, for papers by Clare F Aldus Breakdown of academic impact, for papers by N Calvert Breakdown of academic impact, for papers by Farzad Ebrahimzadeh Breakdown of academic impact, for papers by Rosemary Johann‐Liang Breakdown of academic impact, for papers by Peter Hunter
Rankless by CCL
2026